Replies to post #71826 on Muscle Pharm Corporation (MSLPQ)

[TheExpertHimself]

The new business model of Musclepharm requires a cost focus....every penny counts.

This is not the kind of company that pays departing employees particularly well.

Musclepharm is not a pharmaceutical company that negotiates with insurance companies...it is not a p/s=5. Musclepharm negotiates with big box retailers, that don't pay it that well.

At best p/s=2 in an acquisition and at best at p/s=1 otherwise (unless it turns into a Schiff Nutrition kind of company).

I hope we see the transformation coming in 2015...that Musclepharm means this for real....because if that is the case, it's not a $10 stock anymore...it should be an $18 stock by next Summer.